Key facts
- It has raised $2.5M; the latest was Grant ($1.0M) in Oct 2025.
- Notable investors include US National Science Foundation, Capital Factory, JumpStart, Tecnológico de Monterrey, Venturance Alternative Assets — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Asclepii
- ·The full record, as it builds
Funding rounds
No funding rounds for Asclepii are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Asclepii
Operator of a medical device company intended to offer wound healing products. The company focuses on regenerative medicine in wound healing and is an international healthcare technology designer and manufacturer to tackle challenging health problems with innovations that accessibly transform lives, enabling patients to get proper cures for their wounds through scale-focused manufacturing & product development.
- Sector
- Healthcare
- HQ
- Cleveland, OH, United States
- Founded
- 2022
- Employees
- 20
- Website
- asclepii.com/
- Ownership
- Privately Held (backing)
Asclepii doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Asclepii shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Asclepii in its N-PORT filings yet. We sweep new filings monthly.